Review on Nanoparticle Based Buccal Drug Delivery System
Обзор систем трансбуккальной доставки лекарственных средств на основе наночастиц
2025-08-02
SCID: 54.1/8q5y9bfh
Discuss with AI
bioavailabilitybuccal mucosadrug permeabilitynanocarriersnanoparticle-based buccal drug delivery
Figures from the paper
Abstract (AI)
The administration of drug through buccal mucosa has gain lot of attention in drug delivery system. The main advantages of using buccal route is non-invasive and easy method to administer the drug and it bypasses the gastrointestinal tract and avoids first pass metabolism in the liver that lead to reduced side effects. However, the buccal drug delivery faces many challenges like low permeability, enzyme degradation and drug absorption typically inadequate to provide effective therapy because of tongue movement, high salivary excretion and accidental swallowing. The use of nanoparticle is a key method for improving buccal administration because the nanoparticle act as versatile nanocarriers than can increase the bioavailability of loaded drug and improve permeability and drug absorption in buccal mucosa since they can stay in systemic circulation for long period of time and reduce side effects. Many drugs have been formulated as nanoparticle based buccal delivery system such as lipid-based nanoparticle, liposomes, nanoparticle lipid carriers, polymerics, etc., which are used in the treatment of various diseases. This review article highlights the buccal drug delivery, anatomy of oral cavity and various strategies used to target the buccal mucosa. Also, this review summarizes the recent advance nanotechnology method focused on formulations that have been developed to enhance drug delivery through buccal mucosa.
Key Findings
1
Buccal administration is limited by low mucosal permeability, enzymatic degradation, salivary clearance, tongue movement, and accidental swallowing.
2
Buccal drug delivery is non-invasive, easy to administer, bypasses the gastrointestinal tract, and avoids hepatic first-pass metabolism.
3
Lipid-based nanoparticles, liposomes, nanostructured lipid carriers, and polymeric nanoparticles have been developed for buccal delivery of drugs targeting various diseases.
4
Nanoparticles can enhance buccal drug delivery by improving mucosal permeability, drug absorption, bioavailability, and circulation time while potentially reducing side effects.
5
The review summarizes buccal anatomy, targeting strategies, and recent nanotechnology-based formulations designed to improve drug transport across buccal mucosa.
Research Object
nanoparticle-based buccal drug delivery systems
Research Subject
formulation strategies and performance for enhancing drug permeability, absorption, bioavailability, and therapeutic delivery through the buccal mucosa
Publication Details
Publication Date
2025-08-02
Journal
Publisher
ISSN
Cited by
1
Access Type
Author Information
Download PDF
Subscribe to digest